Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL3 | Q96JM7 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | HTR2C | P28335 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1190916 | 1.00 | HTR6 (1.00) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 | |
| SCHEMBL3522066 | 1.00 | HTR6 (1.00) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 | |
| SCHEMBL8499402 | 0.98 | HTR6 (0.96) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 | |
| SCHEMBL398118 | 0.98 | HTR6 (0.96) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 | |
| Hydrochloric Acid SCHEMBL63700 | 0.98 | HTR6 (0.96) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 | |
| SCHEMBL8502194 | 0.98 | HTR6 (0.96) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 | |
| SCHEMBL8501091 | 0.98 | HTR6 (0.96) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 | |
| SCHEMBL8503565 | 0.98 | HTR6 (0.96) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 | |
| Hydrochloric Acid SCHEMBL20522843 | 0.98 | HTR6 (0.96) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 | |
| SCHEMBL6314141 | 0.96 | HTR6 (0.92) | HTR6KMT2AHPGDSMN1; SMN2L3MBTL3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 714 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024173530-A1 | HETEROARYL-SUBSTITUTED PYRAZOLO/IMIDAZO PYRIDINE COMPOUNDS | IDEAYA BIOSCIENCES, INC. (US) | 2024-08-22 | — | — | WO | claimed |
| WO-2024173514-A1 | AMIDE AND ESTER-SUBSTITUTED IMIDAZOPYRIDINE COMPOUNDS | IDEAYA BIOSCIENCES, INC. (US) | 2024-08-22 | — | — | WO | claimed |
| WO-2024173453-A1 | HETEROARYL-SUBSTITUTED IMIDAZOPYRIDINE COMPOUNDS | IDEAYA BIOSCIENCES, INC. (US) | 2024-08-22 | — | — | WO | claimed |
| WO-2024173524-A1 | HETEROARYL-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS | IDEAYA BIOSCIENCES, INC. (US) | 2024-08-22 | — | — | WO | claimed |
| EP-3994137-A1 | HETEROCYCLIC MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2022-05-11 | — | — | EP | claimed |
| EP-3020744-B1 | Two-component polyurethane adhesive composition | 3M INNOVATIVE PROPERTIES CO (US) | 2020-12-30 | — | — | EP | claimed |
| US-20170335046-A1 | TWO-COMPONENT POLYURETHANE ADHESIVE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY | 2017-11-23 | — | — | US | claimed |
| US-9750719-B2 | Tetrazole compounds as calcium channel blockers | Convergence Pharmaceuticals Limited (GB) | 2017-09-05 | — | — | US | claimed |
| WO-2016077511-A1 | TWO-COMPONENT POLYURETHANE ADHESIVE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-05-19 | — | — | WO | claimed |
| EP-3020744-A1 | Two-component polyurethane adhesive composition | 3M Innovative Properties Company (US) | 2016-05-18 | — | — | EP | claimed |
| WO-2009026326-A1 | NAPHTHYLPYRIMIDINE, NAPHTHYLPYRAZINE AND NAPHTHYLPYRIDAZINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM | WYETH (US) | 2009-02-26 | — | — | WO | claimed |
| EP-1756107-A2 | ARYL-SUBSTITUTED PIPERAZINE DERIVATIVES | NEUROGEN CORPORATION (US) | 2007-02-28 | — | — | EP | claimed |
| WO-2006009789-A2 | ARYL-SUBSTITUTED PIPERAZINE DERIVATIVES | NEUROGEN CORPORATION (US) | 2006-01-26 | — | — | WO | claimed |
| EP-1070065-A1 | AZABICYCLIC 5HT1 RECEPTOR LIGANDS | Pfizer Products Inc. (US) | 2001-01-24 | — | — | EP | claimed |
| WO-1999052907-A1 | AZABICYCLIC 5HT1 RECEPTOR LIGANDS | PFIZER PRODUCTS INC. (US) | 1999-10-21 | — | — | WO | claimed |
| EP-0646116-B1 | PROCESS AND INTERMEDIATES FOR BIS-AZA-BICYCLIC ANXIOLYTIC AGENTS | PFIZER (US) | 1999-10-13 | — | — | EP | claimed |
| EP-0573467-B1 | NEUROLEPTIC PERHYDRO-1H-PYRIDO 1,2-a]PYRAZINES | PFIZER (US) | 1995-05-31 | — | — | EP | claimed |
| EP-0573467-A1 | NEUROLEPTIC PERHYDRO-1H-PYRIDO 1,2-a]PYRAZINES. | PFIZER (US) | 1993-12-15 | — | — | EP | claimed |
| US-5157034-A | Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines | PFIZER INC. (US) | 1992-10-20 | — | — | US | claimed |
| WO-1992015580-A1 | NEUROLEPTIC PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES | PFIZER INC. (US) | 1992-09-17 | — | — | WO | claimed |